Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- Nanoparticles (4)
- Chitosan (3)
- Drug delivery (3)
- Nanomedicine (3)
- Prodrug (3)
-
- CRISPR (2)
- Critical Quality Attributes (CQAs) (2)
- HIV (2)
- LC-MS (2)
- LC-MS/MS (2)
- Lipid nanoparticles (2)
- MS Method Development (2)
- Microfluidics (2)
- Nanoparticle (2)
- RNA (2)
- RNA Identification (2)
- RNA Quantification (2)
- RNA therapeutics (2)
- RNA-LNP (2)
- SiRNA (2)
- Top-Down MS (2)
- Zein (2)
- ACE2 host receptor (1)
- AIDS (1)
- ALI (1)
- ARDS (1)
- Adsorption of excipients (1)
- Allosteric interactions (1)
- Antibacterial activity (1)
- Antidiabetic (1)
- Publication Year
- Publication
-
- Theses & Dissertations (7)
- Nanotechnology Research Centre (3)
- Theses and Dissertations (3)
- Honors Scholar Theses (2)
- Pharmacy (2)
-
- Pharmacy Faculty Articles and Research (2)
- Theses and Dissertations--Pharmacy (2)
- Dissertations, Theses, and Capstone Projects (1)
- Electronic Theses and Dissertations (1)
- Graduate Research Posters (1)
- Honors Program: Senior Projects (Public) (1)
- LSU Doctoral Dissertations (1)
- Maaen Journal for Medical Sciences (1)
- Mathematics, Physics, and Computer Science Faculty Articles and Research (1)
- Pharmaceutical Sciences (MS) Theses (1)
- Research Colloquium (1)
- Theses and Dissertations--Chemistry (1)
- University Scholar Projects (1)
- Publication Type
Articles 31 - 32 of 32
Full-Text Articles in Nanotechnology
Chitosan Nanoparticle Modifications For Improved Gene Delivery In An Oral Dna Vaccine Application, Austin Helmink
Chitosan Nanoparticle Modifications For Improved Gene Delivery In An Oral Dna Vaccine Application, Austin Helmink
Honors Program: Senior Projects (Public)
Vaccines represent one of the most significant medical innovations of the 20th century, resulting in the eradication or near eradication of a handful of deadly diseases. However, many infectious diseases remain resistant to effective vaccination, largely due to a lack full immune activation by traditional protein-based vaccines. A promising alternative vaccination strategy is the emerging development of DNA vaccines, which rely upon the delivery of exogenous genetic material to host cells encoding for a viral or bacterial antigen in order to induce a robust immune response by closely mimicking live infection. The delivery of genetic material requires a carrier …
Bsa Nanoparticles For Sirna Delivery: Coating Effects On Nanoparticle Properties, Plasma Protein Adsorption, And In Vitro Sirna Delivery, Haran Yogasundaram, Markian Stephan Bahniuk, Harsh-Deep Singh, Hamidreza Montazeri Aliabadi, Hasan Uludag, Larry David Unsworth
Bsa Nanoparticles For Sirna Delivery: Coating Effects On Nanoparticle Properties, Plasma Protein Adsorption, And In Vitro Sirna Delivery, Haran Yogasundaram, Markian Stephan Bahniuk, Harsh-Deep Singh, Hamidreza Montazeri Aliabadi, Hasan Uludag, Larry David Unsworth
Pharmacy Faculty Articles and Research
Developing vehicles for the delivery of therapeutic molecules, like siRNA, is an area of active research. Nanoparticles composed of bovine serum albumin, stabilized via the adsorption of poly-L-lysine (PLL), have been shown to be potentially inert drug-delivery vehicles. With the primary goal of reducing nonspecific protein adsorption, the effect of using comb-type structures of poly(ethylene glycol) (1 kDa, PEG) units conjugated to PLL (4.2 and 24 kDa) on BSA-NP properties, apparent siRNA release rate, cell viability, and cell uptake were evaluated. PEGylated PLL coatings resulted in NPs with ζ-potentials close to neutral. Incubation with platelet-poor plasma showed the composition of …